Adaptive Biotechnologies Corporation revenue breakdown overview

Adaptive Biotechnologies Corporation revenue for the last year amounted to 178.96 M USD, the most of which — 133.03 M USD — came from its highest performing source at the moment, Minimal Residual Disease - Service, the year earlier bringing 102.74 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Adaptive Biotechnologies Corporation 178.96 M USD, and the year before that — 170.28 M USD.